AZD 7009
CAS No. 864368-79-6
AZD 7009( AZD7009 )
Catalog No. M16266 CAS No. 864368-79-6
AZD 7009 is a novel antiarrhythmic agent that inhibits the late sodium current in CHO K1 cells expressing hNav1.5 with IC50 of 11 uM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAZD 7009
-
NoteResearch use only, not for human use.
-
Brief DescriptionAZD 7009 is a novel antiarrhythmic agent that inhibits the late sodium current in CHO K1 cells expressing hNav1.5 with IC50 of 11 uM.
-
DescriptionAZD 7009 is a novel antiarrhythmic agent that inhibits the late sodium current in CHO K1 cells expressing hNav1.5 with IC50 of 11 uM; also inhibits late sodium current in isolated rabbit atrial and ventricular myocytes, attenuates the E-4031-induced action potential duration prolongation, induces early afterdepolarisations (EADs) in Purkinje fibres.Heart Arrhythmia Phase 2 Discontinued.
-
In Vitro——
-
In Vivo——
-
SynonymsAZD7009
-
PathwayMembrane Transporter/Ion Channel
-
TargetSodium Channel
-
RecptorSodium Channel
-
Research AreaCardiovascular Disease
-
IndicationHeart Arrhythmia
Chemical Information
-
CAS Number864368-79-6
-
Formula Weight446.548
-
Molecular FormulaC23H34N4O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN1(CC2OC(C1)CN(C2)CCNC(=O)OC(C)(C)C)C[C@@H](COc1ccc(C#N)cc1)O
-
Chemical Nametert-butyl N-[2-[3-[(2S)-3-(4-cyanophenoxy)-2-hydroxypropyl]-9-oxa-3,7-diazabicyclo[3.3.1]nonan-7-yl]ethyl]carbamate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Goldstein RN, et al. J Cardiovasc Electrophysiol. 2004 Dec;15(12):1444-50.
2. Persson F, et al. J Cardiovasc Electrophysiol. 2005 Mar;16(3):329-41.
3. Persson F, et al. J Cardiovasc Pharmacol. 2005 Jul;46(1):7-17.
4. Persson F, et al. Eur J Pharmacol. 2007 Mar 8;558(1-3):133-43.
molnova catalog
related products
-
PF-05150122
PF-05150122 is a potent, state-dependent, subtype selective Nav1.7 inhibitor with IC50 of 21 nM.
-
Eslicarbazepine
Eslicarbazepine can be used for adjunctive therapy for adults with partial-onset seizures.
-
Anemoside B4
Anemoside B4 inhibits the secretion of IL-10.